ALIPAY+
15.7.2024 09:33:27 CEST | Business Wire | Press release
In a fiercely contested UEFA EURO 2024™, Dani Olmo (Spain), Harry Kane (England), Cody Gakpo (Netherlands), Georges Mikautadze (Georgia), Ivan Schranz (Slovakia), and Jamal Musiala (Germany) emerged as joint winners of the Alipay+ Top Scorer award. Each player scored three goals during the tournament, showcasing exceptional performances throughout and contributing to a memorable event that concluded with a thrilling final at Berlin's Olympiastadion.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240714542692/en/
Eric Jing, Chairman and CEO of Ant Group, presents the Alipay+ Top Scorer award to the onsite winning football player Dani Olmo of Spain at UEFA EURO 2024™ (Photo: Business Wire)
“Our warmest congratulations to the six exceptional football players for their stellar performances and for winning the Alipay+ Top Scorer award,” said Eric Jing, Chairman and CEO of Ant Group, while presenting the award at the Berlin Olympiastadion. “Just as these athletes push the boundaries of excellence with strength, ingenuity and teamwork, Alipay+ advances global commerce through digital innovation, empowering people and businesses worldwide.”
Alipay+, a suite of cross-border mobile payment and digitalization technology solutions operated by Ant International, is the Official Partner of UEFA EURO 2024™. The Alipay+ Top Scorer trophy, sculpted in the shape of the Chinese character “支” (pronounced zhi, meaning payment as well as support), reflects Alipay+’s dedication to supporting consumers to enjoy seamless cross-border payment and access personalised deals when using their preferred payment methods while traveling abroad.
The character also resembles the fleeting moment of a barefooted striker poised to shoot, evoking the original beauty and power of football – a game that unit people across the world with passion, ambition, and solidarity. The base of the trophy resembles the ocean, consisting of 24 undulating pieces each inscribed with the names of the participating countries, while the design symbolizes the 24 teams braving the waves at the competition. The ocean also connects continents, which represents how football connects communities across the world similar to Alipay+ connecting global commerce.
Alipay+ has now enabled over 400,000 merchants in Europe, with over 120,000 in the DACH region alone. Among the 15 Alipay+ mobile partners in Germany are Alipay (Chinese mainland), AlipayHK (Hong Kong SAR, China), MPay (Macao SAR, China), Touch ’n Go eWallet and MyPB by Public Bank Berhad (Malaysia), Hipay (Mongolia), GCash (The Philippines), OCBC Digital and Changi Pay (Singapore), TrueMoney (Thailand), Tinaba (Italy), Bluecode (Germany and Austria) and Kakao Pay, Naver Pay and Toss Pay (South Korea).
“With Alipay+ and our global partnerships, global fans and visitors explore Germany, Europe and the bigger world seamlessly using their preferred payment methods. Digital commerce connects communities worldwide just like football,” said Jing. “Looking ahead, we are committed to advancing digital technologies for everyone, supporting a robust, inclusive, and sustainable global digital economy.”
About Alipay+
Alipay+ is a suite of cross-border mobile payment and digitalization technology solutions that help connect global merchants to consumers. Consumers enjoy seamless payment and a broad choice of deals using their preferred payment methods while traveling abroad. Small and medium-sized businesses may use Alipay+ digital tools to enhance efficiency and achieve omni-channel growth.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240714542692/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom